Microvascular dysfunction in patients with diabetes after cardioplegic arrest and cardiopulmonary bypass

Jun Feng1, Frank Sellke

  • 1Division of Cardiothoracic Surgery, Department of Surgery, Cardiovascular Research Center, Rhode Island Hospital, Alpert Medical School of Brown University, Rhode Island Hospital, Rhode Island, USA *Both the authors contributed equally to the writing of this article.

Insights

This review details microvascular function changes in diabetic patients undergoing cardiac surgery with cardioplegia and cardiopulmonary bypass (CPB). Understanding these diabetes-related alterations can improve patient outcomes post-surgery.

Area of Science:

  • Cardiovascular Medicine
  • Diabetology
  • Vascular Biology

Background:

  • Cardiac surgery involving cardioplegia and cardiopulmonary bypass (CPB) significantly impacts microvascular function.
  • Patients with diabetes, particularly those with poor glycemic control, exhibit more profound microvascular alterations.
  • These changes contribute to increased morbidity and mortality following cardiac procedures.

Purpose of the Study:

  • To review and describe the specific changes in microvascular function observed in diabetic patients after cardioplegia/CPB and cardiac surgery.
  • To highlight the critical role of microvascular dysfunction in the outcomes of these patients.
  • To emphasize the need for a deeper understanding of diabetes-related microvascular regulation.

Main Methods:

  • Literature review focusing on studies examining microvascular function.
  • Analysis of research on vascular reactivity, permeability, gene/protein expression, and apoptosis.
  • Synthesis of findings related to diabetic patients undergoing cardiac surgery with cardioplegia/CPB.

Main Results:

  • Cardiac surgery with cardioplegia/CPB induces significant changes in coronary and peripheral microcirculation.
  • Diabetic patients experience exacerbated alterations in vascular reactivity, permeability, and cell death pathways.
  • Impaired vasomotor regulation is a key factor in the heightened risks faced by diabetic patients.

Conclusions:

  • Understanding the specific microvascular dysfunctions in diabetes is crucial for improving surgical outcomes.
  • Targeting diabetes-related microvascular alterations may reduce morbidity and mortality post-cardiac surgery.
  • Further research into diabetic microvascular regulation can inform better perioperative management strategies.
Abstract